Free Trial

Amrize Ltd $AMRZ Shares Sold by Neuberger Berman Group LLC

Amrize logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Neuberger Berman Group LLC cut its position in Amrize by 53.5%, selling 43,824 shares in Q3 and leaving 38,033 shares valued at about $1.835 million.
  • Amrize beat EPS expectations with $0.62 vs. $0.59 consensus, but revenue missed at $2.84 billion versus $2.95 billion and was down 0.4% year‑over‑year.
  • Several brokers raised price targets and the stock has a consensus "Moderate Buy" with a $64.14 target, yet shares were down 5.4%, opening at $58.22 (market cap ≈ $32.2B).
  • Five stocks we like better than Amrize.

Neuberger Berman Group LLC decreased its position in shares of Amrize Ltd (NYSE:AMRZ - Free Report) by 53.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 38,033 shares of the company's stock after selling 43,824 shares during the period. Neuberger Berman Group LLC's holdings in Amrize were worth $1,835,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. State of Wyoming purchased a new position in shares of Amrize during the third quarter worth approximately $32,000. US Bancorp DE purchased a new stake in Amrize in the 3rd quarter valued at $38,000. Costello Asset Management INC purchased a new stake in Amrize in the 3rd quarter valued at $44,000. Global Retirement Partners LLC acquired a new stake in Amrize during the 3rd quarter worth $48,000. Finally, Jones Financial Companies Lllp acquired a new stake in Amrize during the 3rd quarter worth $53,000.

Amrize Stock Down 5.4%

Shares of NYSE AMRZ opened at $58.22 on Friday. The stock has a market capitalization of $32.20 billion and a price-to-earnings ratio of 23.67. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94. The firm has a 50-day moving average price of $57.64 and a 200 day moving average price of $53.44. The company has a quick ratio of 1.10, a current ratio of 1.64 and a debt-to-equity ratio of 0.37.

Amrize (NYSE:AMRZ - Get Free Report) last issued its earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.03. The company had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.95 billion. The business's quarterly revenue was down .4% compared to the same quarter last year.

Analysts Set New Price Targets

Several brokerages have issued reports on AMRZ. Royal Bank Of Canada raised their price objective on shares of Amrize from $60.00 to $61.00 and gave the stock a "sector perform" rating in a research report on Thursday, February 19th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of Amrize in a research note on Monday, February 23rd. JPMorgan Chase & Co. raised their price target on Amrize from $60.00 to $70.00 and gave the stock an "overweight" rating in a report on Thursday. Wells Fargo & Company upped their price objective on Amrize from $59.00 to $66.00 and gave the company an "overweight" rating in a research note on Thursday, February 19th. Finally, Citigroup lifted their target price on Amrize from $63.00 to $67.00 and gave the company a "buy" rating in a research note on Thursday, January 8th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $64.14.

Read Our Latest Research Report on AMRZ

Insider Activity at Amrize

In other news, CFO Ian A. Johnston purchased 1,200 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were acquired at an average price of $63.92 per share, for a total transaction of $76,704.00. Following the acquisition, the chief financial officer directly owned 18,544 shares in the company, valued at approximately $1,185,332.48. The trade was a 6.92% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines